1. Home
  2. Clinical Topics
  3. FDA approves Gardasil for prevention of anal cancer
Clinical TopicsDrugs and DevicesHealthcare & TechnologyImmune/Lymphatic SystemInfection PreventionInfectious DiseasesNewsOncologyPediatricsWeb Exclusives

FDA approves Gardasil for prevention of anal cancer

Share

The U.S. Food and Drug Administration (FDA) has approved the vaccine Gardasil for the prevention of anal cancer and associated precancerous lesions because of human papillomavirus (HPV) types 6, 11, 16, and 18 in people ages 9 through 26 years. Read more here.

Leave a Reply

Your email address will not be published.

Fill out this field
Fill out this field
Please enter a valid email address.

Get your free subscription to NurseLine!

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Recent Posts